Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.260
-0.090 (-6.67%)
At close: Jun 27, 2025, 4:00 PM
1.330
+0.070 (5.56%)
After-hours: Jun 27, 2025, 7:53 PM EDT
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $117.19 million as of June 27, 2025. Its market cap has decreased by -39.51% in one year.
Market Cap
117.19M
Enterprise Value
-69.04M
1-Year Change
-39.51%
Ranking
Category
Stock Price
$1.26
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $117.19M, a decrease of -86.81%. That is a compound annual growth rate of -40.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2025 | 119.05M | -17.32% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.21B |
| Johnson & Johnson | 365.06B |
| AbbVie | 329.06B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.68B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.66B |
| AstraZeneca | 216.45B |